Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 1501 AL 1515

The management of gastrointestinal symptoms in Parkinson's disease

Salat-Foix D, Suchowersky O.

Expert Rev Neurother. 2012 Feb;12(2):239-48. doi: 10.1586/ern.11.192.

Gaucher disease and the synucleinopathies: refining the relationship

Campbell TN, Choy FY.

Orphanet J Rare Dis. 2012 Jan 31;7:12. doi: 10.1186/1750-1172-7-12.

Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease

Di Giacopo R, Fasano A, Quaranta D, Della Marca G, Bove F, Bentivoglio AR.

Mov Disord. 2012 Apr;27(4):559-61. doi: 10.1002/mds.24909. Epub 2012 Jan 30.

Factors associated with the severity and progression of self-reported hand pain and functional difficulty in community-dwelling older adults: a systematic review

Nicholls EE, van der Windt DA, Jordan JL, Dziedzic KS, Thomas E.

Musculoskeletal Care. 2012 Mar;10(1):51-62. doi: 10.1002/msc.1007. Epub 2012 Jan 31.

Monitoring oxidative stress biomarkers in the lipidome: is there a roadmap for "human inspection"?

Jungnickel H, Tentschert J, Luch A.

Curr Mol Med. 2012 Jul 1;12(6):716-31. doi: 10.2174/156652412800792606.

A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson's disease

Pouclet H, Lebouvier T, Coron E, Des Varannes SB, Neunlist M, Derkinderen P.

Neurogastroenterol Motil. 2012 Apr;24(4):e202-5. doi: 10.1111/j.1365-2982.2012.01887.x. Epub 2012 Jan 31.

Rapid recovery from congestive heart failure following successful radiofrequency catheter ablation in a patient with late onset of Wolff-Parkinson-White syndrome

Yodogawa K, Ono N, Seino Y.

Intern Med. 2012;51(3):277-80. doi: 10.2169/internalmedicine.51.6044. Epub 2012 Feb 1.

Sequestosome 1/p62: across diseases

Geetha T, Vishwaprakash N, Sycheva M, Babu JR.

Biomarkers. 2012 Mar;17(2):99-103. doi: 10.3109/1354750X.2011.653986. Epub 2012 Feb 1.

Positron emission tomography imaging in neurological disorders

Politis M, Piccini P.

J Neurol. 2012 Sep;259(9):1769-80. doi: 10.1007/s00415-012-6428-3.

Stress, allostatic load, catecholamines, and other neurotransmitters in neurodegenerative diseases

Goldstein DS.

Cell Mol Neurobiol. 2012 Jul;32(5):661-6. doi: 10.1007/s10571-011-9780-4.

Knotting of percutaneous endoscopic jejunostomy feeding tubes in two patients with Parkinson's disease and continuous Duodopa® treatment

Krones E, Zollner G, Petritsch W.

Z Gastroenterol. 2012 Feb;50(2):213-6. doi: 10.1055/s-0031-1281998. Epub 2012 Feb 1.

Assessment of substantia nigra echogenicity in German and Filipino populations using a portable ultrasound system

Go CL, Frenzel A, Rosales RL, Lee LV, Benecke R, Dressler D, Walter U.

J Ultrasound Med. 2012 Feb;31(2):191-6. doi: 10.7863/jum.2012.31.2.191.

The role of ER stress-induced apoptosis in neurodegeneration

Stefani IC, Wright D, Polizzi KM, Kontoravdi C.

Curr Alzheimer Res. 2012 Mar;9(3):373-87. doi: 10.2174/156720512800107618.

Novel approaches to study the involvement of α7-nAChR in human diseases

Palma E, Conti L, Roseti C, Limatola C.

Curr Drug Targets. 2012 May;13(5):579-86. doi: 10.2174/138945012800398838.

α7 nicotinic acetylcholine receptor mediated neuroprotection in Parkinson's disease

Kawamata J, Suzuki S, Shimohama S.

Curr Drug Targets. 2012 May;13(5):623-30. doi: 10.2174/138945012800399026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias